Clinical Trial Update: MWA With or Without Furmonertinib for Early-Stage Non-Small Cell Lung Cancer [NA]

View source ↗

Summary

A clinical trial is evaluating microwave ablation with or without furmonertinib for early-stage non-small cell lung cancer. The study is currently not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Furmonertinib (furmonertinib)

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Lung Cancer (NSCLC) | NA | Status: NOT_YET_RECRUITING